Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RAI”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Testing effectiveness (Phase 2)UnknownNCT04554680
What this trial is testing

Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy

Who this might be right for
Thyroid Cancer
National University Hospital, Singapore 5
Not applicableLooking for participantsNCT06443866
What this trial is testing

I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer

Who this might be right for
Thyroid CancerRAI-Refractory Thyroid Cancer
Miami Cancer Research Center, Inc. 50
Not applicableLooking for participantsNCT07832617
What this trial is testing

Protoacoustic Imaging For 3D Mapping

Who this might be right for
Proton TherapyRadiation Therapy, Secondary Skin ReactionsLiver Cancer+1 more
University of Oklahoma 24
Testing effectiveness (Phase 2)Looking for participantsNCT05783323
What this trial is testing

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid CancerPediatric CancerCancer+1 more
Children's Hospital of Philadelphia 13
Not applicableLooking for participantsNCT02432079
What this trial is testing

Molecular Genetics of Heterotaxy and Related Congenital Heart Defects

Who this might be right for
Heterotaxy SyndromeCongenital Heart Defects
Indiana University 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06458036
What this trial is testing

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Who this might be right for
Differentiated Thyroid CancerPediatric CancerCancer+1 more
Children's Hospital of Philadelphia 13
Testing effectiveness (Phase 2)Study completedNCT00563290
What this trial is testing

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Who this might be right for
Recurrent Skin CancerSquamous Cell Carcinoma of the SkinStage 0 Chronic Lymphocytic Leukemia+1 more
National Cancer Institute (NCI) 7
Large-scale testing (Phase 3)Looking for participantsNCT04290663
What this trial is testing

Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

Who this might be right for
Thyroid CancerIntermediate Risk
Centre Francois Baclesse 368
Not applicableStudy completedNCT04273750
What this trial is testing

RAI & HRS: Relationship Between Relative Adrenal Insufficiency and Failure of Treatment in Hepatorenal Syndrome

Who this might be right for
Liver CirrhosisAcute Kidney InjuryHepato-Renal Syndrome
University Hospital Plymouth NHS Trust 26
Not applicableUnknownNCT02298413
What this trial is testing

Italian Absorb Registry

Who this might be right for
Coronary Artery Disease
Ospedale Santa Croce-Carle Cuneo 1,520
Large-scale testing (Phase 3)Study completedNCT01423032
What this trial is testing

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
WiSP Wissenschaftlicher Service Pharma GmbH 96
Large-scale testing (Phase 3)Study completedNCT04964284
What this trial is testing

RhTSH for Radioactive Iodine Remnant Ablation in Participants With Differentiated Thyroid Cancer (DTC)

Who this might be right for
Differentiated Thyroid Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 390
Not applicableLooking for participantsNCT05024929
What this trial is testing

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Who this might be right for
Papillary Thyroid CancerPediatric CancerDifferentiated Thyroid Cancer
Children's Hospital of Philadelphia 32
Testing effectiveness (Phase 2)UnknownNCT02041260
What this trial is testing

A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting

Who this might be right for
Differentiated Thyroid Cancer (DTC)Poorly Differentiated Thyroid Cancer
Thomas Jefferson University 43
Not applicableStudy completedNCT02988180
What this trial is testing

Intervention on Development and Growth at Children in Poverty

Who this might be right for
Child Malnutrition
Hasselt University 78
Not applicableStudy completedNCT03139162
What this trial is testing

Development of Clinical Indicators From the Swiss RAI-HC

Who this might be right for
Frail Elderly Syndrome
School of Health Sciences Geneva 10,000
Testing effectiveness (Phase 2)Study completedNCT01182285
What this trial is testing

A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin

Who this might be right for
Thyroid Neoplasm
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT02393690
What this trial is testing

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland Carcinoma+8 more
Academic and Community Cancer Research United 60
Testing effectiveness (Phase 2)Study completedNCT03244956
What this trial is testing

Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer

Who this might be right for
Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
Gustave Roussy, Cancer Campus, Grand Paris 40
Large-scale testing (Phase 3)Study completedNCT01876784
What this trial is testing

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 238
Next Page